BL Pharmtech Corp. (KOSDAQ:065170)

Market Cap	25.91B
Revenue (ttm)	6.98B
Net Income (ttm)	-6.02B
Shares Out	26.68M
EPS (ttm)	-225.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,183,027
Average Volume	1,112,790
Open	971.00
Previous Close	747.00
Day's Range	893.00 - 971.00
52-Week Range	376.00 - 2,890.00
Beta	0.72
RSI	76.43
Earnings Date	Mar 20, 2026

About BL Pharmtech

BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 12
• Stock Exchange: KOSDAQ
• Ticker Symbol: 065170

Financial Performance

In 2024, BL Pharmtech's revenue was 8.81 billion, a decrease of -64.10% compared to the previous year's 24.53 billion. Losses were -5.71 billion, 3733.8% more than in 2023.